Women with adverse pregnancy outcomes have an increased risk for cardiovascular disease, as do their adverse pregnancy outcome-free sisters.
Adults with a history of depression have more physical health conditions than those without a history of depression.
Minority groups are less likely to receive standard-of-care diagnostic imaging after abnormal mammography screening.
Tofacitinib and TNF inhibitors demonstrated similar efficacy for managing RA at 12 months, with minor differences noted across tofacitinib treatment lines.
The Food and Drug Administration (FDA) has approved Romvimza ™ (vimseltinib) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will ...
Initiating methotrexate within 2 years of a psoriasis diagnosis is associated with a reduced risk of progressing to PsA.
Pediatric exposures to caffeine energy products increased from 2011 to 2023, although most exposures had minimal clinical effects.
The FDA has accepted for Priority Review the NDA for vatiquinone for the treatment of children and adults living with Friedreich ataxia.
From 2008 to 2017, there was an increase in the prevalence of being free of all disabilities among the US population aged 65 years or older.
The FDA has approved the BLA for Ospomyv™ and Xbryk™, biosimilars to Prolia (denosumab) and Xgeva (denosumab), respectively.
Results of a database review revealed duloxetine, pregabalin, and milnacipran as the only effective pharmacological therapies for managing pain in fibromyalgia.
A recent study finds that childhood and adult traumatic experiences are independently associated with endometriosis.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results